Log In
BCIQ
Print this Print this
 

Krystexxa, pegloticase

Also known as: pegylated urate oxidase (formerly Puricase)

  Manage Alerts
Collapse Summary General Information
Company Horizon Pharma plc
DescriptionPegylated urate oxidase (uricase)
Molecular Target Not available
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentMarketed
Standard IndicationHyperuricemia / gout
Indication Details 
Regulatory Designation EU - Named Patient Program (Treat severe refractory gout)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$630.4M

$120.4M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/14/2016

$510.0M

Undisclosed

Undisclosed

12/16/2013

$120.4M

$120.4M

0

Get a free BioCentury trial today